1887

Abstract

Arbidol (ARB) is an antiviral drug that has broad-spectrum activity against a number of viral infections. To date, there are no specific data regarding its effects against a herpesvirus. Here, the antiviral effect of ARB and structurally related derivatives were evaluated in HaCat cells on different steps of herpes simplex virus type 1 replication: adsorption, entry and post-entry. The simplified pyrrolidine analogue, 9a, showed the best antiviral activity by reducing the plaque numbers by about 50 % instead of 42 % obtained with ARB at the same concentration. Furthermore, we have reported that all tested compounds evaluated for their immunomodulatory activity showed the ability to reduce the viral proteins VP16 and ICP27 and to modify the virus-induced cytokine expression, allowing the host cell a more efficient antiviral response.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.076612-0
2014-11-01
2019-11-21
Loading full text...

Full text loading...

/deliver/fulltext/jmm/63/11/1474.html?itemId=/content/journal/jmm/10.1099/jmm.0.076612-0&mimeType=html&fmt=ahah

References

  1. Amici C., Rossi A., Costanzo A., Ciafrè S., Marinari B., Balsamo M., Levrero M., Santoro M. G.. ( 2006;). Herpes simplex virus disrupts NF-κB regulation by blocking its recruitment on the IκBα promoter and directing the factor on viral genes. . J Biol Chem 281:, 7110–7117. [CrossRef][PubMed]
    [Google Scholar]
  2. Arena A., Bisignano C., Stassi G., Mandalari G., Wickham M. S., Bisignano G.. ( 2010;). Immunomodulatory and antiviral activity of almond skins. . Immunol Lett 132:, 18–23. [CrossRef][PubMed]
    [Google Scholar]
  3. Ayala F., Grimaldi E., Perfetto B., Donnarumma M., De Filippis A., Donnarumma G., Tufano M. A.. ( 2008;). 5-aminolaevulinic acid and photodynamic therapy reduce HSV-1 replication in HaCat cells through an apoptosis-independent mechanism. . Photodermatol Photoimmunol Photomed 24:, 237–243. [CrossRef][PubMed]
    [Google Scholar]
  4. Baroni A., Paoletti I., Ruocco E., Ayala F., Corrado F., Wolf R., Tufano M. A., Donnarumma G.. ( 2007;). Antiviral effects of quinine sulfate on HSV-1 HaCat cells infected: analysis of the molecular mechanisms involved. . J Dermatol Sci 47:, 253–255. [CrossRef][PubMed]
    [Google Scholar]
  5. Boriskin Y. S., Pécheur E. I., Polyak S. J.. ( 2006;). Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection. . Virol J 3:, 56–63. [CrossRef][PubMed]
    [Google Scholar]
  6. Boriskin Y. S., Leneva I. A., Pécheur E. I., Polyak S. J.. ( 2008;). Arbidol: a broad-spectrum antiviral compound that blocks viral fusion. . Curr Med Chem 15:, 997–1005. [CrossRef][PubMed]
    [Google Scholar]
  7. Brancato V., Peduto A., Wharton S., Martin S., More V., Di Mola A., Massa A., Perfetto B., Donnarumma G.. & other authors ( 2013;). Design of inhibitors of influenza virus membrane fusion: synthesis, structure-activity relationship and in vitro antiviral activity of a novel indole series. . Antiviral Res 99:, 125–135. [CrossRef][PubMed]
    [Google Scholar]
  8. Brooks M. J., Sasadeusz J. J., Tannock G. A.. ( 2004;). Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what’s in the pipeline. ? Curr Opin Pulm Med 10:, 197–203. [CrossRef][PubMed]
    [Google Scholar]
  9. Delogu I., Pastorino B., Baronti C., Nougairède A., Bonnet E., de Lamballerie X.. ( 2011;). In vitro antiviral activity of arbidol against Chikungunya virus and characteristics of a selected resistant mutant. . Antiviral Res 90:, 99–107. [CrossRef][PubMed]
    [Google Scholar]
  10. Donnarumma G., De Gregorio V., Fusco A., Farina E., Baroni A., Esposito V., Contaldo M., Petruzzi M., Pannone G., Serpico R.. ( 2010;). Inhibition of HSV-1 replication by laser diode-irradiation: possible mechanism of action. . Int J Immunopathol Pharmacol 23:, 1167–1176.[PubMed]
    [Google Scholar]
  11. Filosa R., Peduto A., de Caprariis P., Saturnino C., Festa M., Petrella A., Pau A., Pinna G. A., La Colla P.. & other authors ( 2007;). Synthesis and antiproliferative properties of N3/8-disubstituted 3,8-diazabicyclo[3.2.1]octane analogues of 3,8-bis[2-(3,4,5-trimethoxyphenyl)pyridin-4-yl]methyl-piperazine. . Eur J Med Chem 42:, 293–306. [CrossRef][PubMed]
    [Google Scholar]
  12. Filosa R., Peduto A., Aparoy P., Schaible A. M., Luderer S., Krauth V., Petronzi C., Massa A., de Rosa M.. & other authors ( 2013;). Discovery and biological evaluation of novel 1,4-benzoquinone and related resorcinol derivatives that inhibit 5-lipoxygenase. . Eur J Med Chem 67:, 269–279. [CrossRef][PubMed]
    [Google Scholar]
  13. Flint S. J., Enquist L. W., Krug R. M., Racaniello V. R., Skalka A. M.. ( 2000;). Principles of Virology, p. 804. Washington, D.C:: American Society for Microbiology;.
    [Google Scholar]
  14. Haid S., Pietschmann T., Pécheur E. I.. ( 2009;). Low pH-dependent hepatitis C virus membrane fusion depends on E2 integrity, target lipid composition, and density of virus particles. . J Biol Chem 284:, 17657–17667. [CrossRef][PubMed]
    [Google Scholar]
  15. Jubelt B., Mihai C., Li T. M., Veerapaneni P.. ( 2011;). Rhombencephalitis/brainstem encephalitis. . Curr Neurol Neurosci Rep 11:, 543–552. [CrossRef][PubMed]
    [Google Scholar]
  16. Keadle T. L., Usui N., Laycock K. A., Miller J. K., Pepose J. S., Stuart P. M.. ( 2000;). IL-1 and TNF-α are important factors in the pathogenesis of murine recurrent herpetic stromal keratitis. . Invest Ophthalmol Vis Sci 41:, 96–102.[PubMed]
    [Google Scholar]
  17. Knipe D. M., Samuel C. E., Palese P.. ( 2001;). Fields Virology, , 4th edn., p. 133. Philadelphia, PA:: Lippincott, Williams & Wilkins;.
    [Google Scholar]
  18. Lai J. S., Herr W.. ( 1997;). Interdigitated residues within a small region of VP16 interact with Oct-1, HCF, and DNA. . Mol Cell Biol 17:, 3937–3946.[PubMed]
    [Google Scholar]
  19. Leneva I. A., Russell R. J., Boriskin Y. S., Hay A. J.. ( 2009;). Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol. . Antiviral Res 81:, 132–140. [CrossRef][PubMed]
    [Google Scholar]
  20. Li H., Zhang J., Kumar A., Zheng M., Atherton S. S., Yu F. S.. ( 2006;). Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells. . Immunology 117:, 167–176. [CrossRef][PubMed]
    [Google Scholar]
  21. Lucey D. R., Clerici M., Shearer G. M.. ( 1996;). Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. . Clin Microbiol Rev 9:, 532–562.[PubMed]
    [Google Scholar]
  22. Melchjorsen J., Sørensen L. N., Paludan S. R.. ( 2003;). Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function. . J Leukoc Biol 74:, 331–343. [CrossRef][PubMed]
    [Google Scholar]
  23. Méndez-Samperio P., Hernandez M., Ayala H. E.. ( 2000;). Induction of transforming growth factor-β 1 production in human cells by herpes simplex virus. . J Interferon Cytokine Res 20:, 273–280. [CrossRef][PubMed]
    [Google Scholar]
  24. Mogensen T. H., Melchjorsen J., Malmgaard L., Casola A., Paludan S. R.. ( 2004;). Suppression of proinflammatory cytokine expression by herpes simplex virus type 1. . J Virol 78:, 5883–5890. [CrossRef][PubMed]
    [Google Scholar]
  25. Nicola A. V., Hou J., Major E. O., Straus S. E.. ( 2005;). Herpes simplex virus type 1 enters human epidermal keratinocytes, but not neurons, via a pH-dependent endocytic pathway. . J Virol 79:, 7609–7616. [CrossRef][PubMed]
    [Google Scholar]
  26. Pécheur E. I., Lavillette D., Alcaras F., Molle J., Boriskin Y. S., Roberts M., Cosset F. L., Polyak S. J.. ( 2007;). Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol. . Biochemistry 46:, 6050–6059. [CrossRef][PubMed]
    [Google Scholar]
  27. Peduto A., Massa A., Di Mola A., de Caprariis P., La Colla P., Loddo R., Altamura S., Maga G., Filosa R.. ( 2011;). 2,3-Dihydro-1,2-Diphenyl-substituted 4H-Pyridinone derivatives as new anti Flaviviridae inhibitors. . Chem Biol Drug Des 77:, 441–449. [CrossRef][PubMed]
    [Google Scholar]
  28. Petronzi C., Filosa R., Peduto A., Monti M. C., Margarucci L., Massa A., Ercolino S. F., Bizzarro V., Parente L.. & other authors ( 2011;). Structure-based design, synthesis and preliminary anti-inflammatory activity of bolinaquinone analogues. . Eur J Med Chem 46:, 488–496. [CrossRef][PubMed]
    [Google Scholar]
  29. Petronzi C., Festa M., Peduto A., Castellano M., Marinello J., Massa A., Capasso A., Capranico G., La Gatta A.. & other authors ( 2013;). Cyclohexa-2,5-diene-1,4-dione-based antiproliferative agents: design, synthesis, and cytotoxic evaluation. . J Exp Clin Cancer Res 32:, 24. [CrossRef][PubMed]
    [Google Scholar]
  30. Pollara G., Jones M., Handley M. E., Rajpopat M., Kwan A., Coffin R. S., Foster G., Chain B., Katz D. R.. ( 2004;). Herpes simplex virus type-1-induced activation of myeloid dendritic cells: the roles of virus cell interaction and paracrine type I IFN secretion. . J Immunol 173:, 4108–4119. [CrossRef][PubMed]
    [Google Scholar]
  31. Roizman B., Knipe D. M.. ( 2001;). Herpes simplex viruses and their replication. . In Fields Virology, , 4th edn., pp. 2399–2460. Edited by Knipe D. M., Howley P. M... Philadelphia:: Lippincott Raven Press;.
    [Google Scholar]
  32. Romagnani S.. ( 1997;). The Th1/Th2 paradigm. . Immunol Today 18:, 263–266. [CrossRef][PubMed]
    [Google Scholar]
  33. Schaible A. M., Traber H., Temml V., Noha S. M., Filosa R., Peduto A., Weinigel C., Barz D., Schuster D., Werz O.. ( 2013;). Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin. . Biochem Pharmacol 86:, 476–486. [CrossRef][PubMed]
    [Google Scholar]
  34. Schelhaas M., Jansen M., Haase I., Knebel-Mörsdorf D.. ( 2003;). Herpes simplex virus type 1 exhibits a tropism for basal entry in polarized epithelial cells. . J Gen Virol 84:, 2473–2484. [CrossRef][PubMed]
    [Google Scholar]
  35. Scherbik S. V., Brinton M. A.. ( 2010;). Virus-Induced Ca2+ Influx Extends Survival of West Nile Virus-Infected Cells. . J Virol 84(17):, 8721–8731. [CrossRef][PubMed]
    [Google Scholar]
  36. Sellitto G., Faruolo A., de Caprariis P., Altamura S., Paonessa G., Ciliberto G.. ( 2010;). Synthesis and anti-hepatitis C virus activity of novel ethyl 1H-indole-3-carboxylates in vitro. . Bioorg Med Chem 18:, 6143–6148. [CrossRef][PubMed]
    [Google Scholar]
  37. Teissier E., Zandomeneghi G., Loquet A., Lavillette D., Lavergne J. P., Montserret R., Cosset F. L., Böckmann A., Meier B. H.. & other authors ( 2011;). Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol. . PLoS ONE 6:, e15874–e15880. [CrossRef][PubMed]
    [Google Scholar]
  38. Us T., Cetin E., Kaşifoğlu N., Kaşifoğlu T., Akgün Y.. ( 2011;). [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus]. . Mikrobiyol Bul 45:, 677–683 (in Turkish).[PubMed]
    [Google Scholar]
  39. Zak-Prelich M., Halliday K. E., Walker C., Yates C. M., Norval M., McKenzie R. C.. ( 2001;). Infection of murine keratinocytes with herpes simplex virus type 1 induces the expression of interleukin-10, but not interleukin-1α or tumour necrosis factor-α. . Immunology 104:, 468–475. [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.076612-0
Loading
/content/journal/jmm/10.1099/jmm.0.076612-0
Loading

Data & Media loading...

Supplements

Supplementary Data 

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error